Something In the Air: A New Risk Factor for Cardiovascular Disease

05/30/23 • 30 min

In episode 13 of the CardiOhio Podcast, we learn about a newly emerging risk factor for cardiovascular disease, air pollution, from a local expert, Dr. Sadeer Al-Kindi from University Hospitals in Cleveland. We review the sources of air pollution in both westernized and developing countries, discuss the evidence for a causative role in development of cardiovascular disease, as well as potential pathophysiologic mechanisms. We conclude by discussing strategies to mitigate risk both at the societal and individual levels.
For more information:
Air Pollution and Cardiovascular Disease: JACC State-of-the-Art-Review
The "Heart" of Environmental Justice

Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.
“Upbeat Party” by scottholmesmusic.com

Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.
“Upbeat Party” by scottholmesmusic.com

Previous Episode

Episode 12: The New Troponins: A Highly Sensitive Topic

Join our host, Drs. Ben Alencherry and Andrew Hornick, along with Ohio-ACC President Dr. Kanny Grewal, clinical cardiologist from OhioHealth Riverside Hospital, as they discuss the practical use of high-sensitivity troponin assays. They review the key differences of the new assays, their role in diagnosis and risk stratification, and tips for transitioning from prior assays.
Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.
For more information, see the 2019 Scientific Expert Panel for Transitioning to High-sensitivity Troponin from ACC.
“Upbeat Party” by scottholmesmusic.com

Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.
“Upbeat Party” by scottholmesmusic.com

Next Episode

Steven Nissen: Reflections of a Master Clinical Trialist

In episode 14 of the CardiOhio Podcast, we interview a legendary clinician, teacher and trialist in American Cardiology, Dr. Steven Nissen from the Cleveland Clinic.
We review his contributions to contemporary trials and lipids and diabetes, as well as his analytic approach to reviewing clinical studies. We then discuss his most recent contribution to the field of lipid therapy, the CLEAR outcomes study published earlier this year.
For additional information on the discussed studies:
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients (CLEAR outcomes study)
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.
“Upbeat Party” by scottholmesmusic.com